Ronaldo Delmonte Piovezan

Ronaldo Delmonte Piovezan

Auto-generated profile, based on publicly available information

Ronaldo Delmonte Piovezan

Adelaide University, College of Health, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Ageing Research Reviews
Verified
Journal Article
Closed access
RPRonaldo D. Piovezan
Ronaldo D. Piovezan
JAJulio Abucham
Julio Abucham
RTRonaldo Thomatieli-Santos
Ronaldo Thomatieli-Santos
Marco Tulio de MelloMarco Tulio de Mello
Marco Tulio de Mello
STSergio Tufik
Sergio Tufik
DPDalva Poyares
Dalva Poyares

1 April 2014 in Sleep Medicine
Verified
Journal Article
Closed access
WMWalter Moraes
Walter Moraes
RPRonaldo Piovezan
Ronaldo Piovezan
DPDalva Poyares
Dalva Poyares
LBLia Bittencourt
Lia Bittencourt
RSRogerio Santos-Silva
Rogerio Santos-Silva
STSergio Tufik
Sergio Tufik

1 November 2019 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
CBConrado Regis Borges
Conrado Regis Borges
DPDalva Poyares
Dalva Poyares
RPRonaldo Piovezan
Ronaldo Piovezan
RNRicardo Nitrini
Ricardo Nitrini
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and is associated with sleep problems. Many previous studies have shown that sleep disorders are risk factors for AD. On the other hand, patients with mild cognitive impairment (MCI) and AD have shown an increased frequency of sleep disorders. This evidence implies an hypothesis of the existence of a bidirectional association between sleep and AD2.

1 June 2015 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
CDCarolina Vicaria Rodrigues D’Aurea
Carolina Vicaria Rodrigues D’Aurea
DPDalva Poyares
Dalva Poyares
RPRonaldo D. Piovezan
Ronaldo D. Piovezan
GPGiselle Soares Passos
Giselle Soares Passos
STSergio Tufik
Sergio Tufik
Marco Tulio de MelloMarco Tulio de Mello
Marco Tulio de Mello
Objective To evaluate the association between objective short sleep duration in patients with insomnia and changes in blood parameters related to hypothalamic-pituitary-adrenal (HPA) axis activity.Method A cross-sectional pilot study was conducted in 30 middle-aged adults with chronic insomnia who were divided into 2 groups according to polysomnography (PSG) total sleep time (TST) (TST > 5h and < 5h). All patients underwent subjective analysis of sleep quality, anthropometric measurements, PSG, and determination off asting blood parameters.Results The results revealed lower sleep efficiency and higher sleep latency for those with a TST < 5h. The subjective sleep quality was worse in the TST < 5h. Significantly, higher glucose and cortisol levels were observed with a TST < 5h. Glucose, cortisol and ACTH levels were inversely correlated with the PSG total sleep time.Conclusion Patients with insomnia with objective short sleep duration had HPA-associated endocrine and metabolic imbalances chronically linked to increases in cardiovascular risk observed with this more severe insomnia phenotype.

Helton de Sá SouzaHelton de Sá Souza
Helton de Sá Souza
CMCamila Maria de Melo
Camila Maria de Melo
RPRonaldo Delmonte Piovezan
Ronaldo Delmonte Piovezan
RMRafael Eduardo Eustórgio Pinheiro Chagas Miranda
Rafael Eduardo Eustórgio Pinheiro Chagas Miranda
MCMiguel Araujo Carneiro-Júnior
Miguel Araujo Carneiro-Júnior
VDVânia D'almeida
Vânia D'almeida
Sleep and exercise have an important role in the development of several inflammation-related diseases, including sarcopenia. Objective: To investigate the effects of 12 weeks of resistance exercise training on sleep and inflammatory status in sarcopenic patients. Methods: A randomized controlled trial comparing resistance exercise training (RET) with a control (CTL) was conducted. Outcomes were obtained by physical tests, polysomnography, questionnaires, isokinetic/isometric dynamometry tests, and biochemical analysis. Results: Time to sleep onset (sleep latency) was reduced in the RET group compared to the CTL group (16.09 ± 15.21 vs. 29.98 ± 16.09 min; p = 0.04) after the intervention. The percentage of slow-wave sleep (N3 sleep) was increased in the RET group (0.70%, CI: 7.27–16.16 vs. −4.90%, CI: 7.06–16.70; p = 0.04) in an intention to treat analysis. Apnea/hour was reduced in the RET group (16.82 ± 14.11 vs. 7.37 ± 7.55; p = 0.001) and subjective sleep quality was improved compared to the CTL (−1.50; CI: 2.76–6.14 vs. 0.00; CI: 1.67–3.84 p = 0.02) in an intention-to-treat analysis. Levels of interleukin-10 (IL-10) (2.13 ± 0.80 vs. 2.51 ± 0.99; p < 0.03) and interleukin-1 receptor antagonist (IL-1ra) (0.99 ± 0.10 vs. 0.99 ± 0.10 ng/mL; p < 0.04; delta variation) were increased in the RET group. Conclusions: RET improves sleep parameters linked to muscle performance, possibly due to an increase in anti-inflammatory markers in older sarcopenic patients.

24 May 2019 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
RPRonaldo D. Piovezan
Ronaldo D. Piovezan
CHCamila Hirotsu
Camila Hirotsu
RMRenato Moizinho
Renato Moizinho
Helton de Sá SouzaHelton de Sá Souza
Helton de Sá Souza
VDVânia D'almeida
Vânia D'almeida
DPDalva Poyares
Dalva Poyares
Background: Evidence suggests anthropometric indicators of obesity are associated with changes in sleep quality and quantity, and the presence of obstructive sleep apnoea (OSA). Investigations including diverse and objective evaluations of sleep and body composition are scarce. We aimed to evaluate the associations between indicators of sleep impairment and body composition states in a sample from a population‐based study.Methods: Participants of the first follow‐up of the EPISONO (São Paulo, Brazil) >50 years were cross‐sectionally evaluated. Sleep was assessed through questionnaires, actigraphy, and polysomnography. Body composition was evaluated by bioelectrical impedance analysis. Appendicular skeletal muscle mass adjusted for body mass index defined sarcopenia (men <0.789 and women 30% and women >40%). The overlap between both conditions defined sarcopenic obesity (SO). Final results were obtained by multinomial logistic regression analysis.Results: Three hundred fifty‐nine adults [mean (standard deviation) age, 61 (8.8) years; 212 (59.1%) female] were enrolled. Obesity was detected in 22.6% of the sample, sarcopenia in 5.6%, and SO in 16.2%. After controlling for covariates, OSA was associated with SO [odds ratio = 3.14, 95% confidence interval (CI) = 1.49–6.61]. Additionally, nocturnal hypoxaemia was associated with both obesity (adjusted odds ratio = 2.59, 95% CI = 1.49–4.49) and SO (odds ratio = 2.92, 95% CI = 1.39–6.13). Other indicators of poor sleep/sleep disorders were not associated with body composition states.Conclusions: Sarcopenic obesity but not obesity alone was associated with OSA. Both obesity and SO but not sarcopenia were associated with nocturnal hypoxaemia. The findings suggest a complex pathophysiologic relationship between adverse body composition states and OSA. Upcoming research on risk factors and therapeutic interventions for OSA should target synchronically the lean and adipose body tissues.